Successful treatment of azole-resistant Candida spondylodiscitis with high-dose caspofungin monotherapy

Rheumatol Int. 2012 Sep;32(9):2957-8. doi: 10.1007/s00296-011-2121-6. Epub 2011 Sep 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Azoles / therapeutic use*
  • Candida albicans / isolation & purification
  • Candidiasis / complications
  • Candidiasis / drug therapy*
  • Caspofungin
  • Discitis / drug therapy*
  • Discitis / microbiology
  • Dose-Response Relationship, Drug
  • Drug Resistance, Fungal*
  • Echinocandins / therapeutic use*
  • HIV Infections / complications
  • HIV Infections / immunology
  • Humans
  • Immunocompromised Host
  • Lipopeptides
  • Male
  • Thoracic Vertebrae / microbiology*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Azoles
  • Echinocandins
  • Lipopeptides
  • Caspofungin